Rheumatic chorea: relationship to systemic manifestations and response to corticosteroids

J Pediatr. 2007 Dec;151(6):679-83. doi: 10.1016/j.jpeds.2007.04.059. Epub 2007 Aug 24.

Abstract

Objective: To describe Sydenham chorea among children in a cohort of patients with rheumatic fever (RF).

Study design: An existing database was used to identify demographic characteristics, clinical manifestations, and therapy in persons with RF identified in Salt Lake City, Utah, from 1985 through January 2002.

Results: Of 584 cases in the database, 537 (91%) were new-onset RF (median age of 10 years) and 177 (33%) had chorea. Patients with chorea were more often female (OR = 0.37, 95% CI = 0.25-0.55, P < .0001) and were less likely to have carditis or arthritis. Prednisone treatment may lead to a shortened course of chorea (4.0 weeks in prednisone-treated [n = 32] vs 9.0 weeks in untreated [n = 14]; P < .0001). Among 33 patients seen at a median of 10.3 years (range 6.3-14.9 years) after their initial bout of chorea, 20% reported residual tremor or mood swings. Ten of the 33 (30%) had one or more recurrences of chorea.

Conclusions: Chorea affected one-third of the children with RF. Patients with chorea were less likely to have severe cardiac or rheumatologic complications of RF. Therapy with prednisone shortened the duration of rheumatic chorea; some reported recurrences of chorea and had minor neurologic sequelae.

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Chorea / drug therapy*
  • Chorea / etiology
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Male
  • Prednisone / therapeutic use*
  • Rheumatic Fever / complications*
  • Risk Factors

Substances

  • Glucocorticoids
  • Prednisone